Helsinki - Delayed Quote EUR
Biohit Oyj (BIOBV.HE)
2.5520
-0.0250
(-0.97%)
At close: 6:12:53 PM GMT+3
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | 0.15 | 0.17 |
| Low Estimate | 0 | 0 | 0.15 | 0.17 |
| High Estimate | 0 | 0 | 0.15 | 0.17 |
| Year Ago EPS | -- | -- | 0.17 | 0.15 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 17M | 19.3M |
| Low Estimate | -- | -- | 17M | 19.3M |
| High Estimate | -- | -- | 17M | 19.3M |
| Year Ago Sales | -- | -- | 14.3M | 17M |
| Sales Growth (year/est) | -- | -- | 18.88% | 13.53% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0.15 | 0.17 |
| 7 Days Ago | 0 | 0 | 0.15 | 0.17 |
| 30 Days Ago | 0 | 0 | 0.16 | 0.18 |
| 60 Days Ago | 0 | 0 | 0.16 | 0.17 |
| 90 Days Ago | 0 | 0 | 0.13 | 0.16 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BIOBV.HE | -- | -- | -11.76% | 13.33% |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Related Tickers
HRTIS.HE Herantis Pharma Oyj
1.4050
-2.77%
FARON.HE Faron Pharmaceuticals Oy
2.4150
-1.02%
TRVI Trevi Therapeutics, Inc.
6.35
+1.28%
IRD Opus Genetics, Inc.
0.7887
+3.79%
FDMT 4D Molecular Therapeutics, Inc.
3.3498
-2.05%
SGMT Sagimet Biosciences Inc.
2.8000
+0.90%
HALO Halozyme Therapeutics, Inc.
59.35
+1.61%
ANNX Annexon, Inc.
1.9050
+3.53%
RCKT Rocket Pharmaceuticals, Inc.
7.41
+3.72%
AVXL Anavex Life Sciences Corp.
9.50
+1.99%